Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2004

View Archived Issues

Cholesterol modulating effects of the LXR agonist T-0901317 in mice are affected by CETP expression

Upregulation of ABCA1 gene expression by LXR agonists to increase low HDL levels

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Immunitor

Further data on Schering-Plough's orally active CCR5 inhibitor against HIV-1

HepeX-C shows efficacy in preventing HCV reinfection

Novel caspase inhibitor against hepatocellular apoptosis

Potential benefits reported for tacrolimus in fulminant hepatic failure

Ilex fully enrolls phase II Campath MS study

Antitubulin agent effective against tumor growth in vivo

Mochida's M-62812 shows potential for the treatment of sepsis and septic shock

Aastrom receives grant to develop immunotherapy for malignant melanoma

Amgen claims new cytokine production inhibitors for inflammation and pain

Novel growth hormone secretagogues identified at BMS

Biogen researchers present new ALK4/ALK5 inhibitors for fibrosis and other disorders

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Oxxon

New CDK inhibitors developed by Schering-Plough and Pharmacopeia team

Pegylated GLP-1 agonists as insulin secretagogues devoid of gastric motility effects

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Phytopharm

Anti-IL-1R1 monoclonal antibodies prepared and tested at Amgen

Peripheral opioid agonists bypass CNS side effects

Antiobesity effects of the histamine H3 antagonist A-331440 shown in mice

Launch of Estrasorb

Japan approves Sandostatin LAR

Phase III trials planned for KW-6002

Advair approved for children aged 4-11 years

Preclinical results for MDI-P in asthma

SuperGen to submit Dacogen NDA on rolling basis

Preclinical studies shed light on molecular pathways of p53

Sinovac SARS vaccine candidates to enter clinic in China

Nymox progresses spheron discoveries in Alzheimer's

Chugai launches Zenol EXUM SX

Codevelopment of ABT-773 suspended

Eisai withdraws E.U. Aricept submission with plans to resubmit

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...